Immune tolerance induction in the era of emicizumab - still the first choice for patients with haemophilia A and inhibitors?

MLA

Katharina Holstein, et al. “Immune Tolerance Induction in the Era of Emicizumab - Still the First Choice for Patients with Haemophilia A and Inhibitors?” Haemophilia : The Official Journal of the World Federation of HemophiliaREFERENCES, vol. 28, no. 2, Nov. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....db206d7d9c86192f9042183e0d5a193a&authtype=sso&custid=ns315887.

APA

Katharina Holstein, Sandra Le Quellec, Robert Klamroth, Angelika Batorova, Pål Andre Holme, Victor Jiménez‐Yuste, & Jan Astermark. (2021). Immune tolerance induction in the era of emicizumab - still the first choice for patients with haemophilia A and inhibitors? Haemophilia : The Official Journal of the World Federation of HemophiliaREFERENCES, 28(2).

Chicago

Katharina Holstein, Sandra Le Quellec, Robert Klamroth, Angelika Batorova, Pål Andre Holme, Victor Jiménez‐Yuste, and Jan Astermark. 2021. “Immune Tolerance Induction in the Era of Emicizumab - Still the First Choice for Patients with Haemophilia A and Inhibitors?” Haemophilia : The Official Journal of the World Federation of HemophiliaREFERENCES 28 (2). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....db206d7d9c86192f9042183e0d5a193a&authtype=sso&custid=ns315887.